In 2011, hc1 was born from the belief that every patient is unique and should be treated that way. When the high-value care movement began, healthcare organizations focused on increasing value through cutting costs, but hc1 knew that sustainable high-value care could only come through improving patient outcomes.
hc1 set about to determine how it could help achieve this goal: Tap into the heartbeat of healthcare—laboratory data. If labs could organize every individual’s information intelligently, they could unlock an unprecedented level of clinical decision support to personalize and improve care for all patients.
Today the hc1 High-Value Care Platform eliminates waste and personalizes care for health systems and diagnostic laboratories nationwide by turning previously static lab data into actionable healthcare insights. Its flagship products, hc1 CRM and hc1 Test Utilization, helped forge a broad set of laboratory and health system partnerships.
Building upon this foundation, in 2018 it introduced a new era of high-value care—precision prescribing—when we invented hc1 Opioid Advisor and hc1 PGx Advisor, which leverage the hc1 platform to optimize medications using targeted pharmacogenetics and medication usage analysis. hc1 PGx Advisor empowers physicians to make personalized prescribing decisions supported by clinical pharmacists with access to holistic patient information, including genetics.
Using the hc1 platform, health systems can improve clinical outcomes and reduce medical spend in these ways:
- Helping labs better serve their physicians and patients
- Ordering all of the tests (and only the tests) a patient needs to achieve timely, accurate diagnosis and treatment
- Identifying the right drugs based on each patient’s unique genetic markers
- Prescribing drugs with the lowest risk of therapy failure and adverse side effects based on a patient’s complete pharmacological history and lifestyle
hc1 is based in Indianapolis, Indiana.